Experiences with shared decision-making in psychotropic medication for people with intellectual disabilities: perspectives of experts by experience, relatives, and support professionals - Takeaways - MDSpire

Experiences with shared decision-making in psychotropic medication for people with intellectual disabilities: perspectives of experts by experience, relatives, and support professionals

  • By

  • Josien Jonker

  • Gerda de Kuijper

  • Evelien Ridder

  • Nynke Scherpbier - de Haan

  • July 3, 2026

  • 0 min

Share

  • 1

    Shared decision-making (SDM) is crucial for person-centred care but faces barriers for individuals with intellectual disabilities (ID).

  • 2

    Individuals with ID often encounter challenges in understanding medical information and communication during SDM processes.

  • 3

    The study identified seven themes related to SDM experiences, including communication quality and the involvement of relatives.

  • 4

    Meaningful involvement in SDM requires tailored information and collaboration among individuals with ID, relatives, and professionals.

  • 5

    Psychotropic medications are frequently prescribed to individuals with ID, raising concerns about overmedication and quality of life.

Original Source(s)

Experiences with shared decision-making in psychotropic medication for people with intellectual disabilities: perspectives of experts by experience, relatives, and support professionals

  • by Josien Jonker, Gerda de Kuijper, Evelien Ridder, Nynke Scherpbier - de Haan

  • July 3, 2026

Related Content

Body-technology interfaces: digital corporeality and emerging psychopathology

From anxiety and depression to non-suicidal self-injury in youths: the mediating effect of neuroticism and the moderating effect of thyroid hormones

Potential profile analysis of return-to-work readiness and self-efficacy in postoperative breast cancer patients who have returned to work